Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Bone and joint infections (BJI), although infrequent (prevalence of 70 per 100,000 in France), have a significant economic and clinical impact. Between 2008 and 2013, the prevalence of BJI increased and infections involving joint prosthesis (PJI) represent a third of BJI in France. They are most often post-operative and more expensive than native IOAs.
This study aims to describe PJI and understand the failure mechanisms of PJI in order to improve their management.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| PJI | Patients having had a PJI |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| PJI | Other | patients having had a PJI managed at the CRIOAc Lyon, with or without relapse |
|
| Measure | Description | Time Frame |
|---|---|---|
| rate of PJI | proportion of PJI among all BJI | between 2018 and 2020 |
| Description of PJI | acute/chronic | between 2018 and 2020 |
| Description of type of prosthesis PJI | number of prosthesis | between 2018 and 2020 |
| Description of patients having had a PJI | type of patients: age | between 2018 and 2020 |
| Description of comorbidities of patients having had a PJI | type of comorbidities.. | between 2018 and 2020 |
| rate of bacteria | epidemiologic description of PJI | between 2018 and 2020 |
| description of antibiotic used | type of antibiotic : name | between 2018 and 2020 |
| description of antibiotic treatment | duration of antibiotic treatment | between 2018 and 2020 |
| description of surgical treatment |
| Measure | Description | Time Frame |
|---|---|---|
| rate of failure | proportion of patients having a failure | between 2018 and 2020 |
| description of the failure | type of failure : persistence or surinfection and management of failure |
Not provided
Inclusion Criteria:
Exclusion Criteria:
-
Not provided
Not provided
Not provided
Not provided
Not provided
patients having had a PJI between 2018 and 2020 managed at the CRIOAc Lyon
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Eugenie Mabrut, CRA | Contact | . 04 26 73 29 38 | eugenie.mabrut@chu-lyon.fr | |
| Tristan Ferry, MD,PhD | Contact | . 04 26 73 29 38 | tristan.ferry@chu-lyon.fr |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hospices Civils de Lyon | Recruiting | Lyon | 69004 | France |
Not provided
| Label | URL |
|---|---|
| Related Info | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D012008 | Recurrence |
| ID | Term |
|---|---|
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
type of surgery: 1-step exchange, 2- step exchange, DAIR
| between 2018 and 2020 |
| between 2018 and 2020 |